China vs India: New or unknown treatment history cases: Pulmonary, bacteriologically
China
326,625
in 2023
India
1.01 million
in 2023
China rank
3rd
India rank
1st
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- China
- India
How they compare
India currently reports 1.01 million against 326,625 in China, a difference of 687,225.
That makes India's figure about 3.1 times China's.
Across all 11 years both countries report, India has been ahead every year.
China ranks 3rd and India ranks 1st of 197 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | China | India | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 241,700 | 783,287 | 541,587 | India |
| 2020s | 297,397 | 866,264 | 568,867 | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, China or India?
- India, at 1.01 million against 326,625 in China as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between China and India?
- 687,225, with India ahead.
- How many years of comparable data are there for China and India?
- 11 years are reported by both, from 2013 to 2023.
- How do China and India rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- China ranks 3rd and India ranks 1st of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.